Dynavax Technologies Corporation (DVAX)

Cash ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Cash and cash equivalents US$ in thousands 95,883 119,332 112,501 132,033 150,279 154,511 226,823 174,350 202,004 198,576 249,091 179,421 436,189 246,351 129,608 79,055 32,073 32,688 60,485 37,899
Short-term investments US$ in thousands 617,951 644,660 623,111 591,505 592,023 565,905 454,702 477,606 422,391 387,910 269,078 323,795 109,761 167,804 216,196 153,619 132,963 144,473 140,223 91,634
Total current liabilities US$ in thousands 78,634 70,030 62,192 56,002 62,195 54,264 44,862 91,515 150,074 244,080 345,198 466,203 556,402 528,935 204,642 109,422 77,411 66,625 53,222 29,279
Cash ratio 9.08 10.91 11.83 12.92 11.94 13.28 15.19 7.12 4.16 2.40 1.50 1.08 0.98 0.78 1.69 2.13 2.13 2.66 3.77 4.42

December 31, 2024 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($95,883K + $617,951K) ÷ $78,634K
= 9.08

The cash ratio of Dynavax Technologies Corporation has shown fluctuations over the given periods. The cash ratio is a liquidity ratio that measures a company's ability to cover its short-term liabilities with its cash and cash equivalents.

As of December 31, 2024, the cash ratio stood at 9.08, indicating that the company had $9.08 of cash and cash equivalents for every $1 of current liabilities. This suggests that the company has a strong ability to meet its short-term obligations using its cash reserves.

The trend of the cash ratio shows a general decline from March 31, 2020, to September 30, 2021, hitting a low point of 0.78. However, from March 31, 2022 onwards, there is a notable recovery in the cash ratio, with significant increases in the ratio observed in the subsequent quarters.

The substantial increase in the cash ratio from June 30, 2023, to March 31, 2024, indicates a significant improvement in the company's liquidity position, with a cash ratio reaching 12.92 by the end of March 2024.

Overall, the upward trend in the cash ratio in the later periods suggests that Dynavax Technologies Corporation has been building up its cash reserves, enhancing its ability to cover short-term obligations and indicating improved liquidity and financial strength.